In our report, we demonstrated that the expression of ANXA3 was not significantly different between tumour and normal tissues, which seemed inconsistent with Bianchi et al. However, we found that high ANXA3 expression was significantly correlated with favourable OS in patients with KIRC. The gene discussed is ANXA3; the disease is neoplasm.